Replies to post #8090 on GTC Biotherapeutics (fka GTCB)

[DewDiligence]

>There is no doubt they have problems communicating with shareholders…<

I respectfully disagree: the communication with shareholders has been excellent, IMO.

What’s been lacking is not communication but rather execution on the financial front. Regards, Dew